RZB is efficacious in reducing signs and symptoms of PsA in patients, regardless of patterns of joint involvement Abs 1504 #ACR @AlexisOgdie @RheumNow https://t.co/AIEJbqrqBf https://t.co/kyiocs8TmL
Links:
Efficacy of Risankizumab in the Treatment of PsA Patients with Limited and Exte…
http://ow.ly/jspk50Lz0j8
13-11-2022